New Product Launch | HiFTra™ PEI Transfection Reagents
Release time:2024-04-19
·Company News


As biotechnology rapidly advances, cell transfection technology has become a cornerstone in cell and gene therapy. Leveraging years of technological expertise and relentless innovation, Pinshan Biotech proudly introduces HiFTra™ PEI transfection reagents, offering both R&D and GMP grades. These reagents boast low cytotoxicity, remarkable transfection efficiency, and easy operation, making them highly adaptable to the varying demands of both fundamental research and commercial production. HiFTra™ PEI transfection reagents can easily cope with various transfection challenges and shall be indispensable transfection tools for researchers and biomedical companies.




Product Highlights


  • Optimized Improvement:HiFTra™ PEI is based on optimized and improved Polyethylenimine Linear (PEI), ensuring superior performance and reliability.
  • High Safty:HiFTra™ PEI undergoes rigorous processing through a 0.1μm PES sterile filter, guaranteeing complete elimination of mycoplasma contamination, thus ensuring high safety for users.
  • Wide Application: HiFTra™ PEI works exceptionally well in the production of viruses like LV and AAV, transient expression of recombinant proteins, and gene transfection in common cell lines such as HeLa and A549.
  • Low Toxicity and High Efficiency: HiFTra™ PEI demonstrates high gene expression efficiency in HEK293 cell lines while maintaining exceptionally low cytotoxicity, striking a perfect balance between safety and performance.
  • GMP Quality Assurance: Offer both R&D-Grade and GMP-Grade products with a reliable quality guarantee, strictly adhering to GMP production standards and having achieved ISO 9001 quality certification.



Why choose HiFTra™ PEI Transfection Reagent?

Currently, cell transfection faces two challenges. Firstly, the elevated toxicity of transfection reagents poses a concern for cell survival rates. Secondly, the incubation period for complex formation is inadequate, preventing the full development of the transfection complex. Conventional transfection reagents available in the market struggle to strike a balance between these two issues. However, Pinshan Biotech's newly introduced HiFTra™ PEI transfection reagent adeptly addresses these challenges. Compared with other brands on the market, HiFTra™ PEI transfection reagent has obvious advantages in product stability, transfection efficiency, cytotoxicity and other aspects, and will be an ideal choice for your research and development and production.



Ordering Information


Storage and Validity

Storage Condition: 2-8 °C
Validity Period: 2 years



Next article:New Product Launch | Ceramic Hydroxyapatite Resin CD-CHT
Previous article:Pinshan Biotech's New R&D Center Launch: Advancing Innovation in Biopharmaceutical Manufacturing Processes
Demo